The Goldman Sachs Group, Inc.
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG000C6CFJ5
GS
The Goldman Sachs Group, Inc.
GICS: 40203020
·
Sector: Financial Services
·
Sub-Sector: Financial - Capital Markets
NAME
The Goldman Sachs Group, Inc.
ISIN
US38141G1040
TICKER
GS
MIC
XNYS
REUTERS
GS.N
BLOOMBERG
GS US
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
Warrants
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Tue, 19.11.2024
Goldman Sachs
US38141G1040
Spectro Cloud, a leader in modern multi-cluster Kubernetes management at scale across a variety of deployment environments, including on-premises hardware, single and multi-cloud, and the edge, today announced it has completed a $75 million Series C funding round led by Growth Equity at Goldman Sachs Alternatives with participation from existing S...
Goldman Sachs
Thu, 17.10.2024
Goldman Sachs
US38141G1040
Today, Goldman Sachs (NYSE:GS) is recognizing Jay Vijayan, Founder and CEO of Tekion, as one of the Most Exceptional Entrepreneurs of 2024 at its Builders and Innovators Summit in Healdsburg, California. This is the third consecutive year Jay is receiving this honor.
This press release features multimedia. View the full release here: https://www.b...
Goldman Sachs
Wed, 16.10.2024
Goldman Sachs
US38141G1040
Today, Goldman Sachs (NYSE: GS) is recognizing Abhinav Shashank, cofounder and CEO of Innovaccer, as one of the Most Exceptional Entrepreneurs of 2024 at its Builders and Innovators Summit in Healdsburg, California.
Goldman Sachs selected Abhinav as a leader from multiple industries to be honored at the two-day event. Abhinav is the driving force...
Goldman Sachs
Wed, 16.10.2024
Goldman Sachs
US38141G1040
Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology company developing the next generation of oncology therapeutics, today announced that Goldman Sachs (NYSE:GS) is recognizing Athena Countouriotis, M.D., Co-founder, President and CEO of Avenzo, as one of the Most Exceptional Entrepreneurs of 2024 at its Builders and Innovators Su...
Goldman Sachs
Information on product placements
